PPA
KURA icon

Parametric Portfolio Associates’s Kura Oncology KURA Stock Holding History

Parametric Portfolio Associates’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$642K Buy
39,942
+3,409
+9% +$49.2K ﹤0.01% 2975
2021
Q4 		$511K Sell
36,533
-44,718
-55% -$724K ﹤0.01% 3064
2021
Q3 		$1.52M Buy
81,251
+52,034
+178% +$980K ﹤0.01% 2588
2021
Q2 		$609K Sell
29,217
-8,314
-22% -$206K ﹤0.01% 3005
2021
Q1 		$1.06M Buy
37,531
+5,392
+17% +$171K ﹤0.01% 3134
2020
Q4 		$1.05M Sell
32,139
-32,660
-50% -$1.15M ﹤0.01% 3023
2020
Q3 		$1.99M Buy
64,799
+51,515
+388% +$1.14M ﹤0.01% 2510
2020
Q2 		$217K Buy
13,284
+222
+2% +$3.2K ﹤0.01% 3605
2020
Q1 		$130K Buy
13,062
+2,611
+25% +$29.9K ﹤0.01% 3669
2019
Q4 		$144K Buy
+10,451
New +$155K ﹤0.01% 3804

Other funds holding KURA

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Parametric Portfolio Associates's KURA Position: Q1 2022 in Review

Parametric Portfolio Associates increased its Kura Oncology (KURA) stake by 9.3% in Q1 2022, buying an estimated $49.2K and bringing the position to 39,942 shares worth $642K. The position accounts for ﹤0.01% of the portfolio, ranked #2975.

Parametric Portfolio Associates first reported a position in KURA in Q4 2019 and has held it in 10 quarters since. The position peaked at $1.99M in Q3 2020. 152 funds tracked by Wall St. Rank hold KURA as of Q1 2022.

  • Parametric Portfolio Associates held 39,942 shares of Kura Oncology worth $642K as of Q1 2022.
  • Parametric Portfolio Associates bought 3,409 Kura Oncology shares in Q1 2022, an estimated $49.2K.
  • Kura Oncology made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2975 holding.
  • Parametric Portfolio Associates first reported a position in Kura Oncology in Q4 2019 and has held it in 10 quarters since.
  • Parametric Portfolio Associates's Kura Oncology position peaked at $1.99M in Q3 2020.
  • 152 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.